戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ciated with reduced duration and severity of cold symptoms.
2 2 to 3 hours while awake as long as they had cold symptoms.
3 ciated with respiratory tract infections and cold symptoms.
4 what role, if any, zinc may play in treating cold symptoms.
5 zinc from zinc gluconate as long as they had cold symptoms.
6 c group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.
7 ns of nasal aspirates when they were without cold symptoms and again during self-reported respiratory
8 acebo (n = 75) within 24 hours of developing cold symptoms and were assessed clinically, with relevan
9                       All subjects developed cold symptoms, and infection was confirmed by culturing
10 ugh their patterns of transmission and their cold symptoms are broadly similar to those of the major
11 .34, 95% CI = 1.55-3.52, P < .0001) and with cold symptoms, as reported concurrently with sampling an
12 rus increased the likelihood of experiencing cold symptoms, asthma symptoms, or both compared with is
13 ffect of treatment on the severity of common cold symptoms cannot be accurately assessed with current
14  infection also caused increased severity of cold symptoms compared with other viral infections.
15                    Time to resolution of all cold symptoms did not differ significantly between stude
16 ciated with reduced duration and severity of cold symptoms, especially cough.
17 es have been shown to reduce the duration of cold symptoms in adults.
18  ZGG lozenges were not effective in treating cold symptoms in children and adolescents.
19 icacy of any therapy for treatment of common cold symptoms in children less than 6 years of age and i
20 pments in the supportive treatment of common cold symptoms in children.
21 ymptoms in asthmatic patients but suppressed cold symptoms in healthy subjects.
22 , S pneumoniae was associated with increased cold symptoms (mean, 2.7 [95% CI, 2.0-3.5] vs 1.8 [95% C
23 ible beneficial effects of zinc gluconate on cold symptoms outweigh the possible adverse effects.
24 NA ratio were inversely related to both peak cold symptoms (r(s) = -0.60, p < 0.005) and the time to
25                                          The cold symptom severity (Jackson score) did not differ bet
26                      The primary outcome was cold symptom severity, which was assessed using daily sc
27                We related the improvement in cold symptoms to the antioxidant and anti-inflammatory p
28 ulture samples for rhinovirus were obtained, cold symptoms were assessed, and volunteer activities we
29             The subjective scores for common cold symptoms were recorded daily.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。